Compound Detail
CHEMBL88327
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL88327 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SXNVXANLVJMHQR-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
336.8
MW (Da)
3.35
ALogP
5
HBA
0
HBD
61.8
PSA (Ų)
0.79
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.58
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| C6-BU-1 CHEMBL614532 | IC50 | 7.58 | 7.58 | 26.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| C6-BU-1 | IC50 | = | 26.0 | nM | 7.58 | IKCa channel inhibition was determined measuring ionomycin-induced Rb+ efflux of... | 12873483 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12873483 | 10.1016/s0960-894x(03)00560-2 | C6-BU-1 | 1 |
Data from ChEMBL 36 via Core Engine